Meet the AI startup using your health data to help drug companies target ads - Business Insider

But while annoying to some, the commercials could end up saving someone's life. At least, that's what DeepIntent CEO and founder Chris Paquette hopes.

The product was in beta testing with several large, undisclosed pharmaceutical companies. DeepIntent's website touts AstraZeneca, Bayer, Merck, and GlaxoSmithKline as clients, among others. Overall, it works with seven of the top 10 largest drugmakers, according to Paquette. Hypothetically, DeepIntent could figure out that, say, 45-year-old men who live in southern states and watch late-night television have higher rates of Type 2 diabetes. Those findings could then inform where a drug company that sells medication to treat that disease should purchase advertisements.

The company says its platform can be up to 60% more effective than traditional methods. It bases that metric on insights including audience quality, which can tie back how effective it was in reaching the right audience in a federally compliant manner.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Inside Calibrate, The Telehealth Newcomer Using Doctors And Coaches To Disrupt The $70 Billion Weight Loss IndustryOn Wednesday, 30 Under 30 alumnae Isabelle Kenyon unveiled Calibrate, a telehealth company meant to change the conversation around metabolic health. It launches with $5.1 million in a seed round led by Kirsten Green's Forerunner Ventures. mcgrathmag Breaking News: Did Obama/Biden just admit to Treason and conspiracy? mcgrathmag Gives me a strong Theranos vibe jtread0000 mcgrathmag If it is plugged by Forbes it is filed with perpetual motion machines.
Source: Forbes - 🏆 394. / 53 Read more »